Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):e1046-e1081. doi: 10.1161/CIR.0000000000000624. Epub 2018 Nov 10. Erratum in: Circulation. 2019 Jun 18;139(25):e1178-e1181. PubMed PMID: 30565953.
Anderson TJ, Grégoire J, Pearson GJ, et al. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Review. PubMed PMID: 27712954.
Dyslipidemias are conditions in which plasma concentrations of lipids, lipoproteins, or triglycerides are considered elevated based on the patient’s total cardiovascular disease risk.
Total cholesterol, high-density cholesterol, and triglycerides used to be measured in the fasting state after 12 to 14 hours since the last meal. New guidelines suggest that lipid measurement could be done in a nonfasting state for the purpose of risk assessment and screening, but fasting measurements should be taken while assessing the efficacy of treatment, especially in patients with elevated triglyceride levels.
Low-density lipoprotein levels are usually calculated using the Friedewald formula:
|LDL-C = TC – HDL-C – (TG/5 [mg/dL] or TG/2.2 [mmol/L])|
Where: LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride.
The calculations are unreliable in patients with a triglyceride level >4.6 mmol/L (400 mg/dL).